DRD2 and schizophrenia: Dopamine is the other player in the pathophysiology of schizophrenia, as also demonstrated by the mechanism of action of antipsychotic drugs that, despite differences in receptor profiles, act mainly on the positive symptoms, as antagonists of D2R [42,257,258,259,260,261,262].